Report Code: 12170 | Available Format: PDF | Pages: 280
Precision Medicine Market Research Report: By Type (Therapeutics, Diagnostics, Personalized Medical Care) - Global Industry Analysis and Growth Forecast to 2030
- Report Code: 12170
- Available Format: PDF
- Pages: 280
- Report Description
- Table of Contents
- Market Segmentation
- Request Free Sample
Chapter 1. Research Background
1.1 Research Objectives
1.2 Market Definition
1.3 Research Scope
1.3.1 Market Segmentation by Type
1.3.2 Market Segmentation by Region
1.3.3 Analysis Period
1.3.4 Market Data Reporting Unit
1.3.4.1 Value
1.4 Key Stakeholders
Chapter 2. Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.2.1 Breakdown of Primary Research Respondents
2.2.1.1 By region
2.2.1.2 By industry participant
2.2.1.3 By company type
2.3 Market Size Estimation
2.4 Data Triangulation
2.5 Assumptions for the Study
Chapter 3. Executive Summary
Chapter 4. Introduction
4.1 Definition of Market Segments
4.1.1 By Type
4.1.1.1 Therapeutics
4.1.1.2 Diagnostics
4.1.1.2.1 Esoteric lab services
4.1.1.2.2 Esoteric tests
4.1.1.2.3 Molecular diagnostics
4.1.1.3 Personalized medical care
4.1.1.3.1 EMR
4.1.1.3.2 Telemedicine
4.1.1.3.2.1 By service
4.1.1.3.2.1.1 Tele consulting
4.1.1.3.2.1.2 Tele monitoring
4.1.1.3.2.1.3 Tele education
4.1.1.3.2.1.4 Tele training
4.1.1.3.2.1.5 Others
4.1.1.3.2.2 By specialty
4.1.1.3.2.2.1 Dermatology
4.1.1.3.2.2.2 Gynecology
4.1.1.3.2.2.3 Cardiology
4.1.1.3.2.2.4 Neurology
4.1.1.3.2.2.5 Orthopedics
4.1.1.3.2.2.6 Others
4.1.1.3.3 DM
4.2 Market Dynamics
4.2.1 Trends
4.2.1.1 Increasing number of clinical trials for precision medicine
4.2.2 Drivers
4.2.2.1 Increasing government support
4.2.2.2 Rising number of approved personalized medicine
4.2.2.3 Growing medical tourism industry
4.2.2.4 Surging use of AI in precision medicine
4.2.2.5 Impact analysis of drivers on market forecast
4.2.3 Restraints
4.2.3.1 High cost for developing a precision medicine
4.2.3.2 Reimbursement policies
4.2.3.3 Impact analysis of restraints on market forecast
4.2.4 Opportunities
4.2.4.1 Companies across APAC are showing interest toward the development of new precision medicine
4.3 Impact of COVID-19
4.3.1 Supply Side Analysis
4.3.1.1 Current scenario of major key players offerings precision medicines
4.3.1.2 Situation of lockdown and workforce availability
4.3.1.3 Production scenario
4.3.1.4 Situation of major countries supplying precision medicines
4.3.2 Demand Side Analysis
4.4 Porter’s Five Forces Analysis
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Intensity of Rivalry
4.4.4 Threat of New Entrants
4.4.5 Threat of Substitutes
Chapter 5. Global Market Size and Forecast
5.1 By Type
5.1.1 Precision Medicine Diagnostics Market, by Type
5.1.2 Personalized Medical Care Market, by Type
5.1.2.1 Telemedicine market, by service
5.1.2.2 Telemedicine market, by specialty
5.2 By Region
Chapter 6. North America Market Size and Forecast
6.1 By Type
6.1.1 Precision Medicine Diagnostics Market, by Type
6.1.2 Personalized Medical Care Market, by Type
6.1.2.1 Telemedicine market, by service
6.1.2.2 Telemedicine market, by specialty
6.2 By Country
6.2.1 U.S. Precision Medicine Market
6.2.1.1 By type
6.2.1.1.1 Precision medicine diagnostics market, by type
6.2.1.1.2 Personalized medical care market, by type
6.2.1.1.2.1 Telemedicine market, by service
6.2.1.1.2.2 Telemedicine market, by specialty
6.2.2 Canada Precision Medicine Market
6.2.2.1 By type
6.2.2.1.1 Precision medicine diagnostics market, by type
6.2.2.1.2 Personalized medical care market, by type
6.2.2.1.2.1 Telemedicine market, by service
6.2.2.1.2.2 Telemedicine market, by specialty
Chapter 7. Europe Market Size and Forecast
7.1 By Type
7.1.1 Precision Medicine Diagnostics Market, by Type
7.1.2 Personalized Medical Care Market, by Type
7.1.2.1 Telemedicine market, by service
7.1.2.2 Telemedicine market, by specialty
7.2 By Country
7.2.1 Germany Precision Medicine Market
7.2.1.1 By type
7.2.1.1.1 Precision medicine diagnostics market, by type
7.2.1.1.2 Personalized medical care market, by type
7.2.1.1.2.1 Telemedicine market, by service
7.2.1.1.2.2 Telemedicine market, by specialty
7.2.2 France Precision Medicine Market
7.2.2.1 By type
7.2.2.1.1 Precision medicine diagnostics market, by type
7.2.2.1.2 Personalized medical care market, by type
7.2.2.1.2.1 Telemedicine market, by service
7.2.2.1.2.2 Telemedicine market, by specialty
7.2.3 U.K. Precision Medicine Market
7.2.3.1 By type
7.2.3.1.1 Precision medicine diagnostics market, by type
7.2.3.1.2 Personalized medical care market, by type
7.2.3.1.2.1 Telemedicine market, by service
7.2.3.1.2.2 Telemedicine market, by specialty
7.2.4 Italy Precision Medicine Market
7.2.4.1 By type
7.2.4.1.1 Precision medicine diagnostics market, by type
7.2.4.1.2 Personalized medical care market, by type
7.2.4.1.2.1 Telemedicine market, by service
7.2.4.1.2.2 Telemedicine market, by specialty
7.2.5 Spain Precision Medicine Market
7.2.5.1 By type
7.2.5.1.1 Precision medicine diagnostics market, by type
7.2.5.1.2 Personalized medical care market, by type
7.2.5.1.2.1 Telemedicine market, by service
7.2.5.1.2.2 Telemedicine market, by specialty
Chapter 8. APAC Market Size and Forecast
8.1 By Type
8.1.1 Precision Medicine Diagnostics Market, by Type
8.1.2 Personalized Medical Care Market, by Type
8.1.2.1 Telemedicine market, by service
8.1.2.2 Telemedicine market, by specialty
8.2 By Country
8.2.1 Japan Precision Medicine Market
8.2.1.1 By type
8.2.1.1.1 Precision medicine diagnostics market, by type
8.2.1.1.2 Personalized medical care market, by type
8.2.1.1.2.1 Telemedicine market, by service
8.2.1.1.2.2 Telemedicine market, by specialty
8.2.2 China Precision Medicine Market
8.2.2.1 By type
8.2.2.1.1 Precision medicine diagnostics market, by type
8.2.2.1.2 Personalized medical care market, by type
8.2.2.1.2.1 Telemedicine market, by service
8.2.2.1.2.2 Telemedicine market, by specialty
8.2.3 India Precision Medicine Market
8.2.3.1 By type
8.2.3.1.1 Precision medicine diagnostics market, by type
8.2.3.1.2 Personalized medical care market, by type
8.2.3.1.2.1 Telemedicine market, by service
8.2.3.1.2.2 Telemedicine market, by specialty
Chapter 9. LATAM Market Size and Forecast
9.1 By Type
9.1.1 Precision Medicine Diagnostics Market, by Type
9.1.2 Personalized Medical Care Market, by Type
9.1.2.1 Telemedicine market, by service
9.1.2.2 Telemedicine market, by specialty
9.2 By Country
Chapter 10. MEA Market Size and Forecast
10.1 By Type
10.1.1 Precision Medicine Diagnostics Market, by Type
10.1.2 Personalized Medical Care Market, by Type
10.1.2.1 Telemedicine market, by service
10.1.2.2 Telemedicine market, by specialty
10.2 By Country
Chapter 11. Competitive Landscape
11.1 Product Benchmarking of Key Players
11.2 Strategic Developments of Key Players
11.2.1 Product Launches and Approvals
11.2.2 Partnerships and Collaborations
11.2.3 Others
Chapter 12. Company Profiles
12.1 Myriad Genetics Inc.
12.1.1 Business Overview
12.1.2 Product and Service Offerings
12.1.3 Key Financial Summary
12.2 Pacific Biosciences of California Inc.
12.2.1 Business Overview
12.2.2 Key Financial Summary
12.3 Partek Inc.
12.3.1 Business Overview
12.4 Randox Laboratories Ltd.
12.4.1 Business Overview
12.4.2 Product and Service Offerings
12.5 Menarini Silicon Biosystems S.p.a.
12.5.1 Business Overview
12.5.2 Product and Service Offerings
12.6 Oracle Corporation
12.6.1 Business Overview
12.6.2 Product and Service Offerings
12.6.3 Key Financial Summary
12.7 23andMe Inc.
12.7.1 Business Overview
12.7.2 Product and Service Offerings
12.8 Precision BioLogic Incorporated
12.8.1 Business Overview
12.8.2 Product and Service Offerings
12.9 EPIC SCIENCES INC.
12.9.1 Business Overview
12.9.2 Product and Service Offerings
12.10 Intomics
12.10.1 Business Overview
12.10.2 Product and Service Offerings
12.11 MDxHealth SA
12.11.1 Business Overview
12.11.2 Product and Service Offerings
12.11.3 Key Financial Summary
12.12 Asuragen Inc.
12.12.1 Business Overview
12.12.2 Product and Service Offerings
12.13 Almac Group Limited
12.13.1 Business Overview
12.13.2 Product and Service Offerings
12.14 International Business Machines Corporation
12.14.1 Business Overview
12.14.2 Product and Service Offerings
12.14.3 Key Financial Summary
12.15 Bristol-Myers Squibb Company
12.15.1 Business Overview
12.15.2 Product and Service Offerings
12.15.3 Key Financial Summary
12.16 Johnson & Johnson
12.16.1 Business Overview
12.16.2 Product and Service Offerings
12.16.3 Key Financial Summary
12.17 Eli Lilly and Company
12.17.1 Business Overview
12.17.2 Product and Service Offerings
12.17.3 Key Financial Summary
12.18 Sanofi
12.18.1 Business Overview
12.18.2 Product and Service Offerings
12.18.3 Key Financial Summary
12.19 Abbott Laboratories
12.19.1 Business Overview
12.19.2 Product and Service Offerings
12.19.3 Key Financial Summary
12.20 Bio-Rad Laboratories Inc.
12.20.1 Business Overview
12.20.2 Product and Service Offerings
12.20.3 Key Financial Summary
12.21 Danaher Corporation
12.21.1 Business Overview
12.21.2 Product and Service Offerings
12.21.3 Key Financial Summary
12.22 F. Hoffmann-La Roche Ltd.
12.22.1 Business Overview
12.22.2 Product and Service Offerings
12.22.3 Key Financial Summary
12.23 bioMérieux S.A.
12.23.1 Business Overview
12.23.2 Product and Service Offerings
12.23.3 Key Financial Summary
12.24 General Electric Company
12.24.1 Business Overview
12.24.2 Product and Service Offerings
12.24.3 Key Financial Summary
12.25 Thermo Fisher Scientific Inc.
12.25.1 Business Overview
12.25.2 Product and Service Offerings
12.25.3 Key Financial Summary
Chapter 13. Appendix
13.1 Abbreviations
11.16 Sources and References
13.2 Related Reports
LIST OF TABLES
TABLE 1 ANALYSIS PERIOD OF THE STUDY
TABLE 2 DRIVERS FOR THE MARKET: IMPACT ANALYSIS
TABLE 3 RETRAINTS FOR THE MARKET: IMPACT ANALYSIS
TABLE 4 GLOBAL PRECISION MEDICINE MARKET, BY TYPE, $B (2019–2024)
TABLE 5 GLOBAL PRECISION MEDICINE MARKET, BY TYPE, $B (2025–2030)
TABLE 6 GLOBAL PRECISION MEDICINE DIAGNOSTICS MARKET, BY TYPE, $B (2019–2024)
TABLE 7 GLOBAL PRECISION MEDICINE DIAGNOSTICS MARKET, BY TYPE, $B (2025–2030)
TABLE 8 GLOBAL PERSONALIZED MEDICAL CARE MARKET, BY TYPE, $B (2019–2024)
TABLE 9 GLOBAL PERSONALIZED MEDICAL CARE MARKET, BY TYPE, $B (2025–2030)
TABLE 10 GLOBAL TELEMEDICINE MARKET, BY SERVICE, $B (2019–2024)
TABLE 11 GLOBAL TELEMEDICINE MARKET, BY SERVICE, $B (2025–2030)
TABLE 12 GLOBAL TELEMEDICINE MARKET, BY SPECIALTY, $B (2019–2024)
TABLE 13 GLOBAL TELEMEDICINE MARKET, BY SPECIALTY, $B (2025–2030)
TABLE 14 GLOBAL PRECISION MEDICINE MARKET, BY REGION, $B (2019–2024)
TABLE 15 GLOBAL PRECISION MEDICINE MARKET, BY REGION, $B (2025–2030)
TABLE 16 NORTH AMERICA PRECISION MEDICINE MARKET, BY TYPE, $M (2019–2024)
TABLE 17 NORTH AMERICA PRECISION MEDICINE MARKET, BY TYPE, $M (2025–2030)
TABLE 18 NORTH AMERICA PRECISION MEDICINE DIAGNOSTICS MARKET, BY TYPE, $M (2019–2024)
TABLE 19 NORTH AMERICA PRECISION MEDICINE DIAGNOSTICS MARKET, BY TYPE, $M (2025–2030)
TABLE 20 NORTH AMERICA PERSONALIZED MEDICAL CARE MARKET, BY TYPE, $M (2019–2024)
TABLE 21 NORTH AMERICA PERSONALIZED MEDICAL CARE MARKET, BY TYPE, $M (2025–2030)
TABLE 22 NORTH AMERICA TELEMEDICINE MARKET, BY SERVICE, $M (2019–2024)
TABLE 23 NORTH AMERICA TELEMEDICINE MARKET, BY SERVICE, $M (2025–2030)
TABLE 24 NORTH AMERICA TELEMEDICINE MARKET, BY SPECIALTY, $M (2019–2024)
Want a report tailored exactly to your business strategy?
Request CustomizationWant an insight-rich discussion with the report author?
Speak to Analyst
Our dedication to providing the most-accurate market information has earned us verification by Dun & Bradstreet (D&B). We strive for quality checking of the highest level to enable data-driven decision making for you
Our insights into the minutest levels of the markets, including the latest trends and competitive landscape, give you all the answers you need to take your business to new heights
With 24/7 research support, we ensure that the wheels of your business never stop turning. Don’t let time stand in your way. Get all your queries answered with a simple phone call or email, as and when required
We take a cautious approach to protecting your personal and confidential information. Trust is the strongest bond that connects us and our clients, and trust we build by complying with all international and domestic data protection and privacy laws